全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

单中心血液透析患者血管钙化情况调查及其危险因素分析
Investigation of the Vascular Calcification Situation among Maintenance Hemodialysis Patients and Analysis of Its Risk Factors in Single Center

DOI: 10.12677/ACM.2023.13112503, PP. 17849-17856

Keywords: 血液透析,血管钙化
Hemodialysis
, Vascular Calcification

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的:了解单中心血液透析患者血管钙化的发生率及严重程度;分析血管钙化的危险因素。方法:对我院血液净化中心规律性维持性血液透析254例患者进行调查。采用多层螺旋CT对冠状动脉钙化进行评分,计算血管钙化的发生率,并根据评分将患者分为非钙化组和钙化组。记录患者年龄、性别、透析龄、有无糖尿病、促红素使用剂量;测定患者血红蛋白、血白蛋白、血钙、血磷、血清全段甲状旁腺素(iPTH)、25-(OH)D3、超敏C反应蛋白(hs-CRP)、血脂、碱性磷酸酶(ALP)。分析血管钙化与透析患者各临床指标的相关性,通过Logistic多因素回归分析,归纳出影响透析患者发生血管钙化的危险因素。结果:本次调查中254例透析患者,CT显示有冠状动脉钙化(钙化组)共有168例(占66.14%),无冠状动脉钙化组(非钙化组)86例(占33.86%)。钙化组和非钙化组比较,患者血红蛋白和血白蛋白,无明显差异(P > 0.05);钙化组年龄、透析龄、血钙、血磷、血钙磷乘积、血iPTH、ALP、hs-CRP、血脂、促红素使用剂量均明显高于非钙化组(P < 0.05);血管钙化组患者25-(OH)D3的水平明显高于非血管钙化组;糖尿病患者和非糖尿病患者比较,动脉钙化发生率明显升高(P < 0.05)。多因素Logistic回归分析显示:血液透析患者的透析龄、年龄、促红素剂量、血钙磷乘积、iPTH、ALP以及合并糖尿病是发生血管钙化的独立危险因素(P < 0.01)。结论:维持性血液透析患者血管钙化发生率高。透析龄、年龄、促红素剂量、血脂、血钙磷乘积、iPTH、ALP以及合并糖尿病是发生血管钙化的独立危险因素。
Objective: To assess the risk factors and analyze the incidence for vascular calcification (VC) in maintenance hemodialysis (MHD) patients in our hospital. Methods: 254 cases of MHD patients in our hemodialysis center were investigated to understand the occurrence of VC. The coronary artery calcification was scored by multi-slice spiral CT. The incidence of vascular calcification was calculat-ed. According to the score, the patients were divided into non calcification group and calcification group. The age, gender, dialysis age, diabetes mellitus and erythropoietin dosage were recorded. Hemoglobin, serum albumin, calcium, phosphorus, iPTH, 25-(OH)D3, high sensitivity C-reactive pro-tein (hs CRP), blood lipid, alkaline phosphatase (ALP) were measured to analyze the correlation between vascular calcification and clinical indicators of dialysis patients, and summarize the risk factors of vascular calcification by logistic regression analysis. Results: 168 cases (66.1%) showed coronary artery calcification by CT, 86 cases (33.86%) in non calcification group without coronary artery calcification. There was no significant difference in hemoglobin and serum albumin between calcification group and non calcification group (P > 0.05). Age, dialysis age, serum calcium, phos-phorus, calcium phosphorus product, iPTH, ALP, hs-CRP, blood lipid and erythropoietin dosage in calcified group were significantly higher than those in non calcification group (P < 0.05). The levels of 25-(OH)D3 was significantly lower than those in non calcification group (P < 0.01). The incidence of arterial calcification in diabetic patients was significantly higher than that in non diabetic pa-tients (P < 0.05). Multivariate logistic regression analysis showed that dialysis age, age, erythropoi-etin dose, calcium phosphorus product, iPTH, ALP and diabetes mellitus were

References

[1]  张勉之, 张敏英, 沈伟梁, 等. 慢性肾功能衰竭原发病的流行病学研究[J]. 中国慢性病预防与控制, 2004, 12(2): 70-72.
[2]  祝全, 赵卫. 尿毒症血透患者眼部与腹主动脉钙化的关系[J]. 西部医学, 2016, 28(2): 204-208.
[3]  Block, G. and Port, F.K. (2003) Calcium Phosphate Metabolism and Cardiovascular Disease in Patients with Chronic Kidney Disease. Seminars in Dialysis, 16, 140-147.
https://doi.org/10.1046/j.1525-139X.2003.160301.x
[4]  肖友文, 潘红霞, 鲍永强, 等. 血液透析患者动静脉内瘘血管壁改变与钙磷代谢的相关性研究[J]. 西部医学, 2017, 29(2): 226-230.
[5]  Greenland, P., Bonow, R.O., Brundage, B.H., et al. (2007) ACCF/AHA 2007 Clinical Expert Consensus Document on Coronary Artery Calcium Scoring by Computed Tomography in Global Cardiovascular Risk Assessment and in Evaluation of Patients with Chest Pain: A Report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). Circu-lation, 115, 402-426.
https://doi.org/10.1161/CIRCULATIONAHA..107.181425
[6]  Abd, E.S., Tripepi, G., Mallamaci, F., et al. (2015) Aldosterone, Mortality, Cardiovascular Events and Reverse Epidemiology in End stage Renal Disease. European Journal of Clinical Investigation, 45, 1077-1086.
https://doi.org/10.1111/eci.12509
[7]  Mujtaba, M.A., Komocsar, W.J., Nantz, E., et al. (2016) Effect of Treatment with Tabalumab, a B Cel-Activating Factor Inhibitor, on Highly Sensitized Patients with End-Stage Renal Disease Awaiting Transplantation. American Journal of Transplantation, 16, 1266-1275.
https://doi.org/10.1111/ajt.13557
[8]  Makarovic, S.Z., Makarovic, R., Steiner, et al. (2015) Osteoprotegerin and Vascular Calcification: Clinical and Prognostic Relevance. Collegium Antropologicum, 39, 461-468.
[9]  国家肾脏疾病临床医学研究中心. 中国慢性肾脏病矿物质和骨异常诊治指南概要[J]. 肾脏病与透析肾移植杂志, 2019, 28(1): 52-57.
[10]  Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group (2017) KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney International Supplements, 7, 1-59.
https://doi.org/10.1016/j.kisu.2017.04.001
[11]  蔡宏, 严玉澄, 陆任华, 等. 腹主动脉钙化评分可预估血液透析患者的冠状动脉钙化程度[J]. 中国血液净化杂志, 2013, 12(4): 189-194.
[12]  陈澄, 覃春美, 欧三桃, 等. II型糖尿病肾病大鼠肾动脉与肾内小动脉钙化及BMP2和Runx2的表达[J]. 西部医学, 2017, 29(2): 154-159.
[13]  邱翠婷, 吕安林. 维生素K依赖蛋白抑制血管钙化研究进展[J]. 中华临床医师杂志(电子版), 2014, 8(13): 2499-2501.
[14]  Pérez-Hernández, N., Aptilon-Duque, G., Blachman-Braun, R., et al. (2017) Vascular Calcification: Current Genetics Underlying This Complex Phenomenon. Chinese Medical Journal (England), 130, 1113-1121.
https://doi.org/10.4103/0366-6999.204931
[15]  吴雪平, 刘成, 陈卫东. 维持性血液透析患者血管钙化情况横断面调查及其危险因素分析[J]. 齐齐哈尔医学院报, 2020, 7(41): 806-811.
[16]  Shanahan, C.M. (2005) Vascular Calcification. Current Opinion in Nephrology and Hypertension, 14, 361-367.
https://doi.org/10.1097/01.mnh.0000172723.52499.38
[17]  徐利鸳, 刘毅, 吴秀娟, 等. 维持性血液透析患者外周血FGF-23水平与血管钙化相关性研究[J]. 中国中西医结合肾病杂志, 2012, 13(4): 323-326.
[18]  韩永魁, 申晓彧. 血管钙化最新相关性研究进展[J]. 中国循证心血管医学杂志, 2020, 12(9): 1144-1146.
[19]  柳诗意, 张宁, 孟祥飞, 等. 补肾活血方通过调节BMP-2/Runx2/Osterix信号通路抑制慢性肾衰竭大鼠血管钙化的实验研究[J]. 中国中西医结合杂志, 2016, 36(3): 327-332.
[20]  周艳, 方炜, 严豪, 等. 炎症、营养不良、瓣膜钙化指标联合预测腹膜透析患者全因死亡和心血管死亡的价值[J]. 上海交通大学学报: 医学版, 2016, 36(9): 1322-1328.
[21]  Rebi, D., Raic, S., Hamzic-Mehmedbaic, A., et al. (2015) Valvular Calcification and Left Ventricular Modifying in Peritoneal Dialysis Patients. Renal Failure, 37, 1316-1322.
https://doi.org/10.3109/0886022X.2015.1073495
[22]  胡绍兰, 杨敏, 白彝华, 等. 营养不良、微炎症状态对腹膜透析患者心血管钙化的影响[J]. 昆明医科大学学报, 2018, 39(7): 47-51.
[23]  Ha, C.M., Park, S., Choi, Y.K., et al. (2014) Activation of Nrf2 by Dimethyl Fumarate Improves Vascular Calcification. Vascular Pharmacology, 63, 29-36.
https://doi.org/10.1016/j.vph.2014.06.007
[24]  Chang, J.-R., Sun, N., Liu, Y., et al. (2020) Erythropoietin Attenuates Vascular Calcification by Inhibiting Endoplasmic Reticulum Stress in Rats with Chronic Kidney Disease. Pep-tides, 1, 196-197.
[25]  He, J., Zhong, X.Y., Zhao, L., et al. (2018) JAK2/STAT3/BMP-2 Axis and NF-κB Pathway Are Involved in Erythropoietin-Induced Calcification in Rat Vascular Smooth Muscle Cells. Clinical and Experimental Nephrology, 23, 501-512.
https://doi.org/10.1007/s10157-018-1666-z

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133